Abstract-Pacing-induced heart failure in the dog recapitulates many of the electrophysiological and hemodynamic abnormalities of the human disease; however, the mechanisms underlying altered Ca 2ϩ handling have not been investigated in this model. We now show that left ventricular midmyocardial myocytes isolated from dogs subjected to 3 to 4 weeks of rapid pacing have prolonged action potentials and Ca 2ϩ transients with reduced peaks, but durations Ϸ3-fold longer than controls. Key Words: excitation-contraction coupling Ⅲ action potential Ⅲ sarcoplasmic reticulum Ⅲ Ca 2ϩ uptake Ⅲ heart failure R ecent evidence indicates that the hemodynamic alterations accompanying heart failure are coincident with a common pattern of electrophysiological and excitation-contraction (E-C) coupling changes at the cellular level. Hallmarks of heart failure include prolongation of the cardiac action potential, 1-4 downregulation of the repolarizing potassium currents I to and I K1 , 1, 5, 6 decreased responsiveness to ␤-adrenergic stimulation, 7-13 and alterations of intracellular Ca 2ϩ handling. 14 -17 Studies of intact cardiac muscles 18 -20 or isolated myocytes 21, 22 indicate that developed force is depressed, relaxation is prolonged, and frequency-dependent facilitation of contraction is blunted in heart failure. These findings may be explained by underlying defects in cellular Ca 2ϩ homeostasis. exchange, the other major Ca 2ϩ removal system of the heart, is apparently upregulated in the failing heart. mRNA levels of the exchanger were shown to be increased 55% to 79% 31,32 in human dilated cardiomyopathy, while the amount of Na ϩ /
Abstract-Pacing-induced heart failure in the dog recapitulates many of the electrophysiological and hemodynamic abnormalities of the human disease; however, the mechanisms underlying altered Ca 2ϩ handling have not been investigated in this model. We now show that left ventricular midmyocardial myocytes isolated from dogs subjected to 3 to 4 weeks of rapid pacing have prolonged action potentials and Ca 2ϩ transients with reduced peaks, but durations Ϸ3-fold longer than controls. To discriminate between action potential effects on Ca 2ϩ kinetics and direct changes in Ca 2ϩ regulatory processes, voltage-clamp steps were used to examine the time constant for cytosolic Ca 2ϩ removal ( Ca ). Ca was prolonged by just 35% in myocytes from failing hearts after fixed voltage steps in physiological solutions ( Ca control, 216Ϯ25 ms, nϭ17; Ca failing, 292Ϯ23 ms, nϭ22; PϽ0.05), but this difference was markedly accentuated when Na ϩ /Ca 2ϩ exchange was eliminated ( Ca control, 282Ϯ30 ms, nϭ13; Ca failing, 576Ϯ83 ms, nϭ11; PϽ0.005). Impaired sarcoplasmic reticular (SR) Ca 2ϩ uptake and a greater dependence on Na ϩ /Ca 2ϩ exchange for cytosolic Ca 2ϩ removal was confirmed by inhibiting SR Ca 2ϩ ATPase with cyclopiazonic acid, which slowed Ca 2ϩ removal more in control than in failing myocytes. ␤-Adrenergic stimulation of SR Ca 2ϩ uptake in cells from failing hearts sufficed only to accelerate Ca to the range of unstimulated controls. Protein levels of SERCA2a, phospholamban, and Na ϩ /Ca 2ϩ exchanger revealed a pattern of changes qualitatively similar to the functional measurements; SERCA2a and phospholamban were both reduced in failing hearts by 28%, and Na ϩ /Ca 2ϩ exchange protein was increased 104% relative to controls. Thus, SR Ca 2ϩ uptake is markedly downregulated in failing hearts, but this defect is partially compensated by enhanced Na ϩ /Ca 2ϩ exchange. The alterations are similar to those reported in human heart failure, which reinforces the utility of the pacing-induced dog model as a surrogate for the human disease. (Circ Res. 1999;84:562-570.) Key Words: excitation-contraction coupling Ⅲ action potential Ⅲ sarcoplasmic reticulum Ⅲ Ca 2ϩ uptake Ⅲ heart failure R ecent evidence indicates that the hemodynamic alterations accompanying heart failure are coincident with a common pattern of electrophysiological and excitation-contraction (E-C) coupling changes at the cellular level. Hallmarks of heart failure include prolongation of the cardiac action potential, [1] [2] [3] [4] downregulation of the repolarizing potassium currents I to and I K1 , 1, 5, 6 decreased responsiveness to ␤-adrenergic stimulation, [7] [8] [9] [10] [11] [12] [13] and alterations of intracellular Ca 2ϩ handling. 14 -17 Studies of intact cardiac muscles 18 -20 or isolated myocytes 21, 22 indicate that developed force is depressed, relaxation is prolonged, and frequency-dependent facilitation of contraction is blunted in heart failure. These findings may be explained by underlying defects in cellular Ca 2ϩ homeostasis. The amplitude of the intracellular Ca 2ϩ transient and its rate of decay have been shown to be reduced in intact muscles 15 exchange, the other major Ca 2ϩ removal system of the heart, is apparently upregulated in the failing heart. mRNA levels of the exchanger were shown to be increased 55% to 79% 31, 32 in human dilated cardiomyopathy, while the amount of Na ϩ / Ca 2ϩ exchange protein was increased 36% to 160% in several studies. [31] [32] [33] [34] It has been suggested that the reduction in SR function, coupled with compensatory upregulation of Na ϩ / Ca 2ϩ exchange, may underlie the blunted force-frequency relation and postrest potentiation evident in heart failure, but it may also serve as a positive inotropic mechanism under Na ϩ -loaded conditions. 32 The present study examines in detail the E-C coupling alterations in the canine ventricular tachycardia-induced heart failure model to investigate the mechanism underlying the prolongation of Ca 2ϩ removal. In addition, the profile of altered Ca 2ϩ regulatory proteins was assessed by Western blot analysis. The finding that the burden of Ca 2ϩ removal is shifted from SR Ca 2ϩ uptake to Ca 2ϩ extrusion via Na ϩ /Ca 2ϩ exchange is similar to what is thought to occur in human heart failure, supporting the notion that a fundamental program of ionic and E-C coupling alterations is induced by heart failure. The contribution of these changes to the shape and duration of the cardiac action potential and intracellular Ca 2ϩ transient are tested by incorporating the experimental results into a computer model of the canine cardiomyocyte, as described in the accompanying study. 35 
Materials and Methods

Pacing-Induced Failure Protocol and Isolation of Midmyocardial Cardiomyocytes
Induction of heart failure and ventricular cardiomyocyte isolation were carried out as described previously 1 using protocols approved by the institution's Animal Care and Use Committee. In brief, mongrel dogs of either sex were anesthetized and surgically instrumented under sterile conditions for implantation of a VVI pacemaker (Medtronics). Rapid pacing at 240 bpm was initiated 1 to 2 days after surgery and maintained for 3 to 4 weeks. At terminal heart failure (verified by hemodynamic measurements), 1 On establishing the whole-cell configuration, 10-mV depolarizing test pulses from a holding potential of -80 mV were applied to examine the passive membrane properties of the myocytes. Cell capacitance (C m ), determined by integrating the area under the capacitive current trace (control, 152Ϯ8 pF, nϭ59; failing, 175Ϯ8 pF; nϭ28), and series resistance (control, 7.8Ϯ1.0 M⍀, nϭ59; failing, 6.1Ϯ0.6 M⍀, nϭ28), determined from the exponential time constant of current decay (R s ϭC m / m ), did not differ between groups. Membrane capacitance and series resistance were electrically compensated by 70 to 75% for an estimated maximal voltage error of Ͻ3 mV in voltage-clamp mode.
Compensation was disabled in current-clamp mode. Data have been corrected post hoc for the measured liquid junction potentials between the pipet and bath solutions as described. 36 The ratio of indo-1 fluorescence (RϭF 405 nm /F 495 nm ) was determined after subtraction of cellular autofluorescence and was used to calculate free intracellular Ca 2ϩ according to the equation 37 using a K d of 844 nmol/L, as reported for rabbit cardiomyocytes. 38 The average R min , R max , and ␤ for the fluorescence system were determined by sequential exposure of cardiomyocytes to (1) a zero-Ca 2ϩ modified Tyrode's solution (other components as described above) containing metabolic inhibitors (10 mmol/L 2-deoxyglucose and 100 mol/L 2,4-dinitrophenol), (2) the same solution with 1 mmol/L EGTA and 20 mol/L ionomycin (for R min ), and (3) and a high Ca 2ϩ Tyrode's solution (5 mmol/L Ca 2ϩ instead of EGTA) for determining R max . R min , R max , and ␤ were 1.24Ϯ0.09, 10.44Ϯ1.85, and 2.7Ϯ0.4, respectively (nϭ10).
The duration of action potential-stimulated Ca 2ϩ transients was determined by measuring the time from electrical stimulation to the half-decay of the transient from its peak (CaD 50 ). The time constant for Ca 2ϩ removal ( Ca ) was determined by fitting a single exponential to the Ca 2ϩ transient during the late phase of repolarization of the action potential or, for voltage clamp pulses, Ϸ20 ms after returning to the holding potential after a stimulus. Peak systolic Ca 2ϩ was measured at steady state for a given stimulation frequency, which usually occurred after 10 to 15 pulses to a single test potential.
Western Blot Analysis
Chunks of left ventricle from the same hearts used for physiological study were freeze-clamped in liquid nitrogen at the time of sacrifice and stored at -80°C. Frozen tissue samples were pulverized with a mortar and pestle, and 10 mL/g of wet tissue weight of lysis buffer was added (pH 7.0) (buffer contained [in mmol/L] NaCl 145, MgCl 2 0.1, HEPES 15, EGTA 10, and Triton X-100 0.5 and protease inhibitors [in mol/L, aminoethyl benzenesulfonyl fluoride 500, aprotinin 0.2, antipain 1.7, leupeptin 1, and chymostatin 10]). After a 30-minute incubation period on ice, the lysate was homogenized (two 15-second bursts) and centrifuged, and the supernatant was aliquoted into tubes and frozen for subsequent analysis. The protein concentration was assayed (BCA kit, Pierce Biochemicals), and 100 L of lysate was added to an equal volume of sample buffer containing 50 mmol/L Tris-HCl, 10% glycerol, 2% SDS, 0.05% bromphenol blue, and 0.3 mmol/L DTT and boiled for 5 minutes. Triplicate samples from 1 control heart and 1 failing heart were loaded on each 5% to 15% polyacrylamide gradient gel (Ready Gel, Bio-Rad) along with duplicate samples from a control heart selected as a reference for data normalization. After electrophoretic separation at 200 V for 30 to 45 minutes in Tris-glycine/SDS buffer (Mini Protean II apparatus, Bio-Rad) proteins were transferred to nitrocellulose membranes (Semi-Dry transfer blot, Bio-Rad), and nonspecific antibody binding was blocked for 1 hour in PBS with 0.1% Tween-20 and 5% nonfat milk. Membranes were washed for 15 minutes in Tween/PBS and then incubated with the primary antibody of interest for 1 hour. Monoclonal anti-SERCA2 (catalog No. MA3-919), anti-PLB (catalog No. MA3-922) and anti-Na ϩ /Ca 2ϩ exchanger (NCX) (catalog No. MA3-926) antibodies were purchased from Affinity BioReagents (Golden, CO). After washout of the primary antibody, membranes were incubated for 1 hour with anti-immunoglobulin horseradish peroxidase secondary antibody and extensively washed again before chemiluminescent detection on Hyperfilm enhanced chemiluminescence (Amersham Life Science, Inc).
Films were digitally scanned into a computer, and band densities were corrected for protein loading (which was approximately equal for all samples on a gel) and normalized to the average density of the reference lanes for comparison of control and failing heart samples. Band density was linearly related to protein loading (data not shown).
Statistical Analysis
Comparisons between groups were made using unpaired Student t tests or, for data spanning a range of conditions (eg, frequency dependence of action potential duration [APD]), by 2-factor ANOVA followed by the Tukey test. ANCOVA was used to examine the relation between the Ca 2ϩ transient duration and APD. A 95% CI was used to determine statistical significance.
Results
Action Potential-Stimulated Ca 2؉ Transients
Action potentials recorded at 37°C with minimal intracellular Ca 2ϩ buffering (80 mol/L indo-1) were prolonged in myocytes from failing hearts ( Figure 1B ) relative to those from control hearts ( Figure 1A ; 6-second cycle length). The morphology of the accompanying Ca 2ϩ transients ( Figure 1A and 1B, bottom panels) also differed, with the majority of transients in cells from failing hearts displaying a biphasic time to peak consisting of a fast peak at 43Ϯ7 ms (nϭ9) after stimulus and a slowly rising phase, which depended on the duration of depolarization. In Figure 1B 35 In contrast, the typical control myocyte had a Ca 2ϩ transient with a rapid time to peak (32Ϯ3 ms, nϭ10; NS with respect to the failing group) and the onset of Ca 2ϩ decay preceding repolarization. Despite a substantial amount of overlap of the data ranges between groups (as evidenced by the scatter plots in Figure 1C ), statistically significant differences in APD with heart failure were evident at both 6-and 1-second cycle lengths ( Figure 1C ). The amplitude of the Ca 2ϩ transient also differed between groups: peak systolic Ca 2ϩ was significantly higher in control myocytes at both the 6-second (control, 908Ϯ218 nmol/L, nϭ8; failing, 363Ϯ125 nmol/L, nϭ9; PϽ0.05) and the 1-second (control, 695Ϯ106 nmol/L, nϭ8; failing, 294Ϯ81 nmol/L, nϭ7; PϽ0.01) stimulus intervals. Although diastolic Ca 2ϩ tended to be lower in myocytes from failing hearts, this difference was not significant (control, 6 seconds, 153Ϯ22 nmol/L, nϭ9; failing, 6 seconds, 64Ϯ42 nmol/L, nϭ9; control, 1 second, 187Ϯ22 nmol/L, nϭ8; failing,1 second, 64Ϯ42 nmol/L, nϭ7).
The duration of the Ca 2ϩ transients, as measured from the stimulus to CaD 50 (illustrated in Figure 2A ) was 3-fold longer in myocytes from failing hearts at the 6-second stimulus interval ( Figure 2B ; control, 362Ϯ55 ms, nϭ9; failing, 1112Ϯ145 ms, nϭ9; PϽ0.001). This difference was substantially less at the 1-second cycle length ( Figure 2B ; control, 342Ϯ30 ms, nϭ7; failing, 404Ϯ66 ms, nϭ7; NS), paralleling the effect of frequency on the APD (compare Figure 1C with Figure 2B ). The latter finding suggested that the duration of the Ca 2ϩ transient was strongly influenced by membrane potential in myocytes from failing hearts. This was supported by correlating CaD 50 with APDs at 90% repolarization (APD 90 ) ( Figure 2D ). CaD 50 in myocytes from failing hearts was more dependent on APD than in controls, particularly at the 6-second cycle length. ANCOVA yielded a coefficient of variation of 0.69 for the failing group compared with 0.18 in controls. By analyzing the late exponentially decaying phase of the Ca 2ϩ transient (as illustrated in Figure 2A) , it was also possible to detect an inherent defect in the time constant for Ca 2ϩ removal ( Ca ) in cells from failing hearts ( Figure 2C) ; however, from action potential-stimulated Ca 2ϩ transients, it is difficult to distinguish inherent changes in Ca 2ϩ regulatory subsystems from altered Ca 2ϩ kinetics secondary to electrophysiological (ie, action potential waveform) changes. Therefore, the various Ca 2ϩ removal subsystems were selectively examined with voltage-clamp techniques.
Voltage-Clamp-Stimulated Ca 2؉ Transients in Physiological Solutions
Voltage-clamp experiments permitted the direct measurement of the Ca 2ϩ removal rate at a fixed voltage (-97 mV) after a 200-ms-long depolarizing step (to ϩ3 mV). Figure 3A and 3B shows representative membrane currents and Ca 2ϩ waveforms for myocytes from control and failing hearts. The membrane current records during the depolarizing step in physiological salt solution reflect overlapping Na ϩ current, L-type Ca 2ϩ current, transient outward K ϩ current, and transient outward Ca 2ϩ -activated Cl Ϫ current, among others; therefore, we did not directly measure the amplitude of I Ca under these conditions (see Figure  4 for comparisons of I Ca between groups in Na ϩ -free, K ϩ -free solutions). No significant difference in resting Ca 2ϩ was evident under these conditions; however, peak systolic Ca 2ϩ was reduced 40% to 50% in cells from failing hearts (mean data are shown in Figure 7 ). The time constant for Ca 2ϩ removal ( Ca ) was 35% longer in the failing group under physiological conditions (control, 216Ϯ25 ms, nϭ17; failing, 292Ϯ23 ms, nϭ22; PϽ0.05; Figure 3E ).
Voltage-Clamp-Stimulated Ca 2؉ Transients in Na ؉ -Free Solutions
The prolongation of Ca in the failing group was markedly accentuated when cells were studied in Na ϩ -free, K ϩ -free intracellular and extracellular solutions ( Figure 3C through 3E, -Na data). Under these conditions, Ca almost exclusively represents the SR Ca 2ϩ uptake rate; mitochondrial and sarcolemmal Ca 2ϩ removal processes likely contribute Ͻ2% to the total Ca 2ϩ decay rate. 39 In control cells, Ca was prolonged by Ϸ30% in Na ϩ -free solution (282Ϯ30 ms, nϭ13) compared with physiological solutions. In cells from failing hearts, Ca was prolonged by 97% (576Ϯ83 ms, nϭ11) relative to that in physiological solutions and was twice as slow as in the control group (PϽ0.005). Since Na ϩ -free conditions effectively eliminate Na ϩ /Ca 2ϩ exchange, the results indicate that myocytes from failing hearts have a greater reliance on Na ϩ /Ca 2ϩ exchange for removing Ca 2ϩ from the cytoplasm during a transient. The Ca in Na ϩ -free solution is 
Effect of Ca 2؉ ATPase Inhibition
A second test of the hypothesis that Na ϩ /Ca 2ϩ exchange accounts for a greater fraction of Ca 2ϩ removal in cells from failing hearts was to determine the rate of Ca 2ϩ removal with SR uptake blocked. The SR Ca 2ϩ ATPase inhibitor CPA (100 mol/L) reduced the amplitude of the Ca 2ϩ transient and greatly prolonged Ca 2ϩ removal in both experimental groups ( Figure 5A ). This effect was larger in the control group, and the final Ca in CPA was 46% slower in the control group than in the failing group ( Figure 5B ). In the presence of CPA, Ca increased by 236Ϯ42% (nϭ9) in myocytes from control hearts as compared with an increase of only 102Ϯ31% (nϭ8; PϽ0.05) in the failing group ( Figure 5C 
Effect of ␤-Adrenergic Stimulation
There is evidence that ␤-adrenergic receptors are decreased in heart failure 7-13 ; thus it was of interest to determine the extent to which the limitations of SR Ca 2ϩ handling could be reversed by inotropic intervention. With Na ϩ /Ca 2ϩ exchange blocked using Na-free solutions, the ability to upregulate SR Ca 2ϩ uptake by ␤-adrenergic stimulation was assessed by treatment with isoproterenol (ISO; 1 mol/L). ISO accelerated Ca in both experimental groups ( Figure 6A) ; however, the absolute Ca remained significantly longer in the failing group under ␤-adrenergic stimulation and fell within the range of unstimulated controls (control Ca , 66Ϯ4 ms, nϭ7; failing Ca , 207Ϯ65 ms, nϭ7; PϽ0.05). The change in Ca (⌬ Ca ) was significantly greater in myocytes from failing hearts ( Figure 6C ), perhaps owing to the slow initial rate, but the percentage decrease in Ca was similar in both groups (Ϸ70%; Figure 6C ).
Effect of Frequency on Ca 2؉ Transients
A significant shift toward transsarcolemmal Ca 2ϩ extrusion coupled with downregulation of SR Ca 2ϩ uptake would be expected to result in decreased loading of the SR at faster pacing frequencies. In this regard, suppressed frequencydependent enhancement of contraction has been demonstrated in human heart failure. 18, 20, 32, 40 In physiological solutions under voltage-clamp conditions, control myocytes had higher peak systolic Ca 2ϩ levels over a wide range of frequencies compared with cells from failing hearts, and the frequency-dependent enhancement of Ca 2ϩ transient amplitude evident in controls at the 1-second cycle length was absent in the failing group (Figure 7) .
Ca
2؉ Regulatory Protein Expression in Heart Failure
Western blots were used to determine whether the physiological changes in Ca 2ϩ handling with heart failure were correlated with altered protein levels of SERCA2, PLB, and NCX. As is clearly evident in the representative western blots shown in Figure 8A , the pattern of altered protein expression in failing hearts was in line with the idea that SERCA2 is downregulated in heart failure. Both SERCA2 and PLB were reduced by Ϸ28% in failing hearts ( Figure 8B) , with no change in the ratio of SERCA2 to PLB. NCX levels were increased by 104% in failing hearts relative to controls ( Figure 8B ). Figure 3A and 3B in myocytes from control (left) and failing (right) hearts in physiological solutions (6-second cycle length). B, Ca before (pre-CPA) and after (CPA) application of CPA (100 mol/L). Exponential fits were made to the falling phase of the transients beginning Ϸ20 ms after repolarization to the holding potential (-97 mV). C, Change (⌬ Ca ; left) and percentage increase (right) in Ca illustrates the greater reliance on Na ϩ /Ca 2ϩ exchange in myocytes from failing hearts. Data shown are meanϩSE. *PϽ0.05.
Discussion
Mechanistic studies of human heart failure are complicated by the prolonged time course of development of the disease, the technical challenges of isolating cardiac tissue or cells from explanted hearts, the inability to investigate the early time course of cellular alterations, and the lack of control over experimental conditions. Thus, it is fortunate that the canine tachycardia-induced heart failure model so closely reproduces the known hemodynamic and ionic changes that have been identified in human hearts. The present findings indicate that, in addition to the electrophysiological changes noted in earlier studies, significant alterations in Ca 2ϩ handling occur in isolated myocytes from failing hearts, following the general pattern of human studies. Through biochemical and functional measurements in the same hearts, we have found strong evidence in support of the hypothesis that the induction of heart failure triggers a shift in the balance of cytosolic Ca 2ϩ extrusion mechanisms from SR Ca 2ϩ uptake toward transsarcolemmal Ca 2ϩ removal. The decrease in peak systolic Ca 2ϩ and prolongation of Ca are in good agreement with data obtained from human myocytes isolated from terminally failing hearts 2, 24 ; however, we observed no statistically significant increase in resting Ca 2ϩ . The latter may be explained if Na ϩ /Ca 2ϩ exchange fully compensates for the reduction of SR Ca 2ϩ uptake in this experimental model. Recent evidence suggests that in human heart failure, the extent of diastolic dysfunction was inversely correlated with upregulation of Na ϩ /Ca 2ϩ exchange protein. 41 Our observations that the level of NCX protein was approximately double that of control hearts, and the lack of a rise in resting Ca 2ϩ , indicate that Na ϩ /Ca 2ϩ exchange effectively compensates for defective SR Ca 2ϩ removal from the cytoplasm. Although there was strong evidence that the fractional contribution of Na ϩ /Ca 2ϩ exchange to Ca 2ϩ removal during a transient was increased in myocytes from failing cells, the relatively small increase in Ca (46%) in the presence of CPA indicates that the function of the NCX may not be increased as much as the protein levels would indicate. This is borne out by the results of the modeling studies, in which only a 53% to 75% functional enhancement of Na ϩ /Ca 2ϩ exchange was estimated by constraining the SR Ca 2ϩ uptake rate to the value determined experimentally in Na-free conditions. 35 The extent of functional enhancement of Na ϩ /Ca 2ϩ exchange activity in the failing heart will require further investigation, including direct measurements of Na ϩ /Ca 2ϩ exchange current; however, even without an increase in the absolute density of Na ϩ /Ca 2ϩ exchange, a substantially larger Na ϩ /Ca 2ϩ exchange current will be generated during an action potential-evoked Ca 2ϩ transient in a failing myocyte, as a result of the reduction in SR Ca 2ϩ uptake. Conversely, the Ϸ30% decrease in SERCA2 protein levels is likely to be an underestimation of the functional impairment of SR Ca 2ϩ uptake, which was 2-fold slower in myocytes from failing hearts (see Figure 3E , -Na bars, and Reference 35).
Impaired SR loading from the combined effect of reduced SR Ca 2ϩ ATPase activity and enhanced transsarcolemmal extrusion could underlie the observed reduction in peak Ca 2ϩ and frequency-dependent facilitation of Ca 2ϩ transient amplitude. In this regard, in a parallel study, we have examined the effects of reducing SR Ca 2ϩ ATPase and increasing Na ϩ /Ca 2ϩ exchange by the amounts determined experimentally in a computer model of the normal and failing canine cardiac cell. 35 The effects on the Ca 2ϩ transient were well reproduced in the model simulations, indicating that these alterations alone are sufficient to account for the data. We have not directly addressed alternative explanations for the failureinduced alterations in Ca 2ϩ handling, which include impaired responsiveness of SR Ca 2ϩ release channels, 42,43 reduced L-type Ca 2ϩ channel-to-SR Ca 2ϩ release channel coupling, 44 or loss of frequency-dependent Ca 2ϩ current facilitation, 45 instead focusing primarily on Ca 2ϩ -removal mechanisms. As in our previous study, 1 we observed no significant difference in peak L-type Ca 2ϩ current density in myocytes from failing hearts when compared with controls; however, in light of the alterations in Ca 2ϩ handling, we would expect that during a given action potential, differences in sarcolemmal subspace Ca 2ϩ in heart failure would significantly influence Ca 2ϩ -dependent fast inactivation of L-type Ca 2ϩ channels. The possible contribution of this effect to action potential prolongation is explored in Winslow et al. 35 The 28% reduction of SERCA2 protein level is close to that reported by Hasenfuss et al 18 for failing human heart. Unlike in earlier studies, however, PLB levels were reduced by a similar amount, and the ratio of SERCA2 to PLB was not changed. Thus, the functional deficit of SR Ca 2ϩ uptake could not be explained by a disproportionately higher amount of PLB but still could involve a difference in the basal phosphorylation state of this protein. Even when phosphorylation was substantially increased by ␤-adrenergic stimulation, the SR Ca 2ϩ uptake rate in myocytes from failing hearts was brought only to the level of unstimulated controls, implying a fundamental limitation to the extent of inotropic reserve through the ␤-adrenergic pathway.
Enhanced Na ϩ /Ca 2ϩ exchange activity during the Ca 2ϩ transient (whether relative or absolute) may prove to be a pivotal mechanistic change occurring in heart failure. The clear beneficial effect of this Ca 2ϩ removal mechanism is that it largely compensates for defective SR Ca 2ϩ uptake. It has also been suggested that enhanced reverse-mode (Ca 2ϩ entry) activity of the exchanger may provide inotropic support in the failing muscle. 32 On the other hand, forward-mode Na ϩ /Ca 2ϩ exchange in the face of slowed SR Ca 2ϩ uptake depletes the releasable pool of Ca 2ϩ with repetitive stimulation, which would effectively unload the SR and alter the frequencydependent response. 39 Furthermore, since the exchanger is electrogenic, it is likely to participate both directly and indirectly (by influencing SR Ca 2ϩ load) in reshaping the action potential in the failing heart. In this regard, the most striking finding of the experimental and modeling studies is that alterations in Ca 2ϩ handling can have major effects on the action potential waveform. In model simulations of minimally Ca 2ϩ -buffered cardiomyocytes, decreasing the density of K ϩ currents has less effect on the duration of the action potential than does suppression of SR Ca 2ϩ uptake with enhanced Na ϩ /Ca 2ϩ exchange. 35 The latter effect may predispose failing heart cells to instabilities of repolarization such as early or delayed afterdepolarizations 46 or to triggered activity, especially in Ca 2ϩ -overloaded myocytes. In summary, canine pacing-induced heart failure leads to alterations of both the electrophysiological and the Ca 2ϩ handling properties of cardiomyocytes that are remarkably similar to those described for the human disease. The increased dependence on Na ϩ /Ca 2ϩ exchange coupled with a reduction of SR Ca 2ϩ uptake not only substantially alters the kinetics and amplitude of the Ca 2ϩ transient, but is likely to contribute to the altered action potential waveform of the failing heart cell. Continued investigation into the interplay between Ca 2ϩ handling and membrane potential will be crucial to understanding the pathophysiology of heart failure.
